Dark
Streaming/Mobile
Old Site
Home
Products
Help
Contact Us
Your Account
System Status
Sign-up for a FREE 30-day Stockwatch subscription and SEE NO ADS
19:44:13 EDT Fri 03 May 2024
Quotes
Streaming/Mobile
Quick Quotes (x20)
Symbol Search
Company Search
Market Depth
US Options
Montreal Options
Foreign Exchange
Download Close Prices
Short History
Quotes Help
Charts
12 Month Chart
Advanced Chart
Live Intraday Chart
Live Historical Chart
Live Java Intraday Chart
Live Java Historical Chart
Charts Help
News
News Search
SEDAR Search
SEDAR Alerts
News Help
Indexes
Major Indexes
US incl Dow Jones
NASDAQ
S&P CME
PBOT - Phil Ex
TSX - Toronto
TSX-V - TSX Venture
Indexes Help
Portfolio
View Portfolio
Portfolio 1
Portfolio 2
Portfolio 3
Portfolio 4
Portfolio 5
Portfolio 6
Portfolio 7
Portfolio 8
Portfolio 9
Portfolio 10
Value Portfolio
All Portfolios
Portfolio 1
Portfolio 2
Portfolio 3
Portfolio 4
Portfolio 5
Portfolio 6
Portfolio 7
Portfolio 8
Portfolio 9
Portfolio 10
Edit Portfolio
Portfolio 1
Portfolio 2
Portfolio 3
Portfolio 4
Portfolio 5
Portfolio 6
Portfolio 7
Portfolio 8
Portfolio 9
Portfolio 10
Chart Portfolio
Portfolio 1
Portfolio 2
Portfolio 3
Portfolio 4
Portfolio 5
Portfolio 6
Portfolio 7
Portfolio 8
Portfolio 9
Portfolio 10
Live Portfolio
Portfolio 1
Portfolio 2
Portfolio 3
Portfolio 4
Portfolio 5
Portfolio 6
Portfolio 7
Portfolio 8
Portfolio 9
Portfolio 10
View Portfolio News
Daily Summary
Portfolio Help
Analytics
Exchange Statistics
Most Active
Live Most Active
Block Trades
Broker Trades
Halted Stocks
Dividends
Participants
Companies
Trade Workstation
Company Picker
Short Positions
Broker Codes
Analytics Help
Mutual Funds
Mutual Fund Search
Targeted Holder Search
SEDAR Fund Search
Mutual Fund Help
Enter Symbol
or Name
USA
CA
Quote
Chart
News
Closes
Depth
Forgot password?
Trouble logging in?
Login to Stockwatch
Q:ADMA
- ADMA BIOLOGICS INC -
https://www.admabiologics.com
19:44:13 EDT
Sym-X
Bid - Ask
Last
Chg
%Ch
Vol
$Vol
#Tr
Open-Hi-Lo
Year Hi-Lo
Last Tr
News
Delay
ADMA
- Q
3.0
6.61
·
6.84
0.1
6.785
+0.045
0.7
2,985.7
19,445
10,578
6.78
6.81
6.65
6.76 3.06
19:10:55
May 02
15 min
RT 2¢
Trade times are ET. News times are ET. Bid/ask/vol sizes in thousands.
Nasdaq Indicators -- Market:
Nasdaq
-- Bid Tick:
Down
-- UPC Restricted:
No
Fundamentals
·
Holders
·
Trade Workstation
·
Market Depth
·
3 Month Closes
·
Technical Charts
1 yr
|
2 yr
|
3 yr
|
5 yr
|
10 yr
|
15 yr
|
20 yr
·
Live Charts
1 yr
|
1 day
·
1yr Bulletins
·
Historical
·
Options
·
Portfolio
Recent Trades - Last 10 of 10578
More trades...
Time ET
Ex
Price
Change
Volume
19:10:55
Q
6.81
0.07
2
18:17:51
Q
6.8089
0.0689
91
18:11:13
Q
6.75
0.01
81
17:43:14
Q
6.66
-0.08
5
17:29:57
Q
6.81
0.07
50,500
17:08:55
Q
6.81
0.07
7
17:03:56
Q
6.79
0.05
2
16:23:53
Q
6.84
0.10
7
16:20:00
Q
6.81
0.07
243
16:11:46
Q
6.8397
0.0997
15
Sign-up for a FREE 30-day Stockwatch subscription and SEE NO ADS
Recent Bulletins
News Releases
In The News
Other
Date ET
Symbol
Type
Headline
2024-05-02 07:00
U:ADMA
News Release
200
ADMA Biologics to Report First Quarter 2024 Financial Results on May 9, 2024
2024-03-11 07:00
U:ADMA
News Release
200
ADMA Biologics Announces FDA Approvals of Extended Room Temperature Storage Conditions for ASCENIV(TM) & BIVIGAM(TM)
2024-03-05 07:00
U:ADMA
News Release
200
ADMA Biologics to Participate in the Raymond James Institutional Investor Conference
2024-02-28 16:10
U:ADMA
News Release
200
ADMA Biologics Announces CFO Transition
2024-02-28 16:05
U:ADMA
News Release
200
ADMA Biologics Announces Fourth Quarter and Full Year 2023 Financial Results and Provides Business Update
2024-02-21 16:05
U:ADMA
News Release
200
ADMA Biologics to Report Fourth Quarter and Full Year 2023 Financial Results on February 28, 2024
2024-02-21 07:00
U:ADMA
News Release
200
ADMA Biologics Successfully Implements Innovative AI Program, Named ADMAlytics
2024-01-08 07:00
U:ADMA
News Release
200
ADMA Biologics Announces Preliminary Fourth Quarter 2023 Revenue and Provides Business Update
2023-12-18 16:05
U:ADMA
News Release
200
ADMA Biologics Announces $135 Million Non-Dilutive Refinancing of Credit Facilities with Ares Management
2023-12-12 07:00
U:ADMA
News Release
200
ADMA Biologics Announces FDA Approval for BIVIGAM ‚ ® in the Pediatric Patient Setting for Those 2 Years of Age and Older
2023-11-16 07:00
U:ADMA
News Release
200
ADMA BioCenters Receives FDA Approval for its Tenth Plasma Collection Center, Located in Laurel, MD
2023-11-08 16:05
U:ADMA
News Release
200
ADMA Biologics Announces Third Quarter 2023 Financial Results and Provides Business Update
2023-11-01 07:00
U:ADMA
News Release
200
ADMA Biologics to Report Third Quarter 2023 Financial Results on November 8, 2023
2023-08-09 16:05
U:ADMA
News Release
200
ADMA Biologics Announces Second Quarter 2023 Financial Results and Provides Business Update
2023-08-02 07:00
U:ADMA
News Release
200
ADMA Biologics to Report Second Quarter 2023 Financial Results on August 9, 2023
2023-07-19 07:00
U:ADMA
News Release
200
ADMA BioCenters Receives FDA Approval for its Ninth Plasma Collection Center, Located in Dallas, GA
2023-05-10 16:05
U:ADMA
News Release
200
ADMA Biologics Announces First Quarter 2023 Financial Results and Provides Business Update